Oncolytics Biotech Inc Cash Flow-to-Debt Ratio
Oncolytics Biotech Inc cash flow-to-debt ratio. Oncolytics Biotech Inc (ONC) has a Cash Flow-to-Debt Ratio of -0.39x as of June 2025, meaning its operating cash flow of CA$-5.47 Million could theoretically repay 0% of its total liabilities (CA$13.88 Million) in one year. Check earnings quality score of Oncolytics Biotech Inc to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Oncolytics Biotech Inc (1999–2024)
Cash flow-to-debt ratio of Oncolytics Biotech Inc from 1999 to 2024. Historical debt coverage capacity for Oncolytics Biotech Inc across 26 annual periods. Check ONC cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Oncolytics Biotech Inc Cash Flow-to-Debt Ratio by Year (1999–2024)
Oncolytics Biotech Inc cash flow-to-debt ratio by year from 1999 to 2024. Year-by-year debt coverage analysis for Oncolytics Biotech Inc. For the full cash flow conversion analysis, see Oncolytics Biotech Inc operating cash flow efficiency.
| Year | CF-to-Debt Ratio | Operating CF (CAD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -1.90x | CA$-26.97 Million | CA$14.20 Million | ▲ +24.9% |
| 2023 | -2.53x | CA$-28.45 Million | CA$11.26 Million | ▼ -17.2% |
| 2022 | -2.16x | CA$-23.36 Million | CA$10.83 Million | ▲ +6.0% |
| 2021 | -2.29x | CA$-22.43 Million | CA$9.78 Million | ▲ +0.3% |
| 2020 | -2.30x | CA$-22.07 Million | CA$9.59 Million | ▼ -128.4% |
| 2019 | -1.01x | CA$-19.91 Million | CA$19.77 Million | ▲ +26.8% |
| 2018 | -1.37x | CA$-11.92 Million | CA$8.67 Million | ▲ +8.9% |
| 2017 | -1.51x | CA$-14.89 Million | CA$9.87 Million | ▲ +50.8% |
| 2016 | -3.07x | CA$-12.48 Million | CA$4.07 Million | ▲ +44.7% |
| 2015 | -5.55x | CA$-15.03 Million | CA$2.71 Million | ▲ +4.9% |
| 2014 | -5.83x | CA$-19.68 Million | CA$3.37 Million | ▼ -43.4% |
| 2013 | -4.07x | CA$-24.44 Million | CA$6.01 Million | ▲ +13.4% |
| 2012 | -4.70x | CA$-34.26 Million | CA$7.29 Million | ▼ -35.6% |
| 2011 | -3.47x | CA$-22.54 Million | CA$6.50 Million | ▲ +51.9% |
| 2010 | -7.21x | CA$-18.03 Million | CA$2.50 Million | ▼ -89.8% |
| 2009 | -3.80x | CA$-16.82 Million | CA$4.43 Million | ▼ -12.7% |
| 2008 | -3.37x | CA$-15.29 Million | CA$4.53 Million | ▲ +29.9% |
| 2007 | -4.81x | CA$-13.57 Million | CA$2.82 Million | ▼ -9.5% |
| 2006 | -4.39x | CA$-12.16 Million | CA$2.77 Million | ▲ +26.8% |
| 2005 | -6.00x | CA$-11.05 Million | CA$1.84 Million | ▲ +28.5% |
| 2004 | -8.39x | CA$-9.22 Million | CA$1.10 Million | ▼ -58.6% |
| 2003 | -5.29x | CA$-5.48 Million | CA$1.03 Million | ▼ -2.9% |
| 2002 | -5.15x | CA$-7.26 Million | CA$1.41 Million | ▼ -275.5% |
| 2001 | -1.37x | CA$-4.27 Million | CA$3.12 Million | ▲ +24.4% |
| 2000 | -1.81x | CA$-3.16 Million | CA$1.74 Million | ▲ +19.9% |
| 1999 | -2.26x | CA$-534.35K | CA$236.10K | — |